Long-term Management of Patients Surgically Treated for Chronic Pelvic Pain by Minimally Invasive Surgery

NCT ID: NCT04652011

Last Updated: 2020-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-01

Study Completion Date

2021-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is a retrospective observational study based on the analysis of the medical records of patients treated for chronic pelvic pain and benign gynecological pathologies at the Gynecology Unit of the University Hospital of Modena from 2010 to 2019. The aim of the study is to analyze the effects of medical and surgical treatments on chronic pelvic pain and associated pathologies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pelvic Pain

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Pelvic Pain Endometriosis Minimally invasive Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with chronic pelvic pain

Patients with chronic pelvic pain and a benign gynecologic disease associated, referring to our Unit, medically or surgically treated from 2010 to 2019

Minimally Invasive Gynecologic Surgery

Intervention Type PROCEDURE

Minimally Invasive Surgery for gynecologic disease (laparoscopy, robotic surgery, vaginal surgery)

osteopathic manipulative treatment

Intervention Type PROCEDURE

Osteopathic manipulative treatment

Pain killer

Intervention Type DRUG

Common pain killer (paracetamol, Ibuprofen, ketoprofen)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Minimally Invasive Gynecologic Surgery

Minimally Invasive Surgery for gynecologic disease (laparoscopy, robotic surgery, vaginal surgery)

Intervention Type PROCEDURE

osteopathic manipulative treatment

Osteopathic manipulative treatment

Intervention Type PROCEDURE

Pain killer

Common pain killer (paracetamol, Ibuprofen, ketoprofen)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Underwent Minimally invasive gynecologic surgery from 2010 to 2019
* Chronic pelvic pain
* Benign gynecologic disease (Endometriosis, myoma, adenomyosis, pelvic organ prolapse

Exclusion Criteria

* malignant gynecologic disease
* chronic pelvic pain not linked to gynecologic disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Azienda Ospedaliero-Universitaria di Modena

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Carlo Alboni, MD, PhD

Dr. Carlo Alboni MD, PhD Head of Minimally Invasive and Robotic Gynecologic Surgery Unit University Hospital of Modena - Italy

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Carlo Alboni

Modena, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Carlo Alboni, MD, PhD

Role: CONTACT

Phone: 0594224387

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Carlo Alboni, MD, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0024582/19

Identifier Type: -

Identifier Source: org_study_id